Abstract: A conjugate compounds or pharmaceutically acceptable salt thereof, comprises a payload and two or more kinds of cell-interacting molecules. The cell-interacting molecules are ligands capable of specifically binding to a cell surface receptor. A method of treating diseases, comprises delivering a payload to a subject.
Type:
Grant
Filed:
August 11, 2016
Date of Patent:
February 7, 2023
Assignee:
Coherent Biopharma I, Limited
Inventors:
Baohua Robert Huang, Jian Dai, Zhongbo Wang, Xueyuan Xie, Xiaodong Liu, Xinli Hu